Drug Trial Radar · NCT06366750
A Study of Barzolvolimab in Patients With Prurigo Nodularis
Last checked: Nov 20, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
140
Actual
Start
Apr 12, 2024
Primary completion
Mar 17, 2026
Study completion Mar 2027
Sponsor
- Lead sponsor
- Celldex TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
Conditions
- Prurigo Nodularis
Interventions
barzolvolimabBiological
subcutaneous administration
Matching PlaceboOther
subcutaneous administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with improvement in Worst Itch Numeric Rating Scale (WI-NRS) by ≥ 4 from baseline to Week 12.Time frame: From Day 1 (first dose) to Day 85 (week 12)
Locations
72 sites in 6 countries. Site status is shown where the registry gives one.
Total Dermatology
Birmingham, Alabama
Cahaba Dermatology Skin Health Center
Birmingham, Alabama
Investigate MD, LLC
Scottsdale, Arizona
Scottsdale Clinical Trials
Scottsdale, Arizona
Center for Dermatology Clinical Research, Inc
Fremont, California
Profound Research LLC
Oceanside, California
Empire Clinical Research
Pomona, California
University of California San Francisco
San Francisco, California
University of California, San Francisco
San Francisco, California
Dermatology Institute & Skin Care Center
Santa Monica, California
Focus Clinical Research
West Hills, California
Encore Medical Research Boynton Beach
Boynton Beach, Florida
Biobrilliance Medical Research Center
Hialeah, Florida
Encore Medical Research
Hollywood, Florida
Life Arc Research Centers Corp
Miami, Florida
University of Miami
Miami, Florida
Advanced Clinical Research Institute
Tampa, Florida
Encore Medical Research of Weston
Weston, Florida
Emory University
Atlanta, Georgia
Centricity Research
Columbus, Georgia
Treasure Valley Medical Research
Boise, Idaho
MetroMed Clinical Trials
Chicago, Illinois
DS Research of Southern Indiana, LLC
Clarksville, Indiana
Equity Medical
Bowling Green, Kentucky
DS Research of Kentucky, LLC
Louisville, Kentucky
Revival Research Institute, LLC
Troy, Michigan
Medisearch, LLC
Saint Joseph, Missouri
Skin Specialists PC
Omaha, Nebraska
University of New Mexico Department of Dermatology
Albuquerque, New Mexico
Equity Medical
New York, New York
Apex Clinical Research Center - Canton
Canton, Ohio
UC Health Physicians Office Dermatology
Cincinnati, Ohio
Paddington Testing, PO
Philadelphia, Pennsylvania
Columbia Dermatology and Aesthetics
Columbia, South Carolina
International Clinical Research - Tennessee LLC
Murfreesboro, Tennessee
Dermatology Treatment and Research Center
Dallas, Texas
Center for Clinical Studies
Webster, Texas
Stratica Dermatology
Edmonton, Alberta, Canada
SimcoDerm Medical and Surgical Dermatology Center
Barrie, Ontario, Canada
Kingsway Clinical Research
Etobicoke, Ontario, Canada
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.